XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholder's Equity - USD ($)
Common Stock
Series C convertible preferred stock
Common Stock
Series D convertible preferred stock
Common Stock
Additional Paid-in Capital
Series C convertible preferred stock
Additional Paid-in Capital
Series D convertible preferred stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive income
Treasury Stock
Series C convertible preferred stock
Series D convertible preferred stock
Total
Balance at Dec. 31, 2023     $ 1,000     $ 346,536,000 $ (309,318,000) $ 32,000 $ (288,000)     $ 36,963,000
Balance (in shares) at Dec. 31, 2023     715,028                  
Stock-based compensation           671,000           671,000
Stock issued under "at-the-market" offering     $ 1,000     3,602,000           3,603,000
Stock issued under "at-the-market" offering (in shares)     569,282                  
Issuance of Common Stock and Warrants, net of issuance costs     $ 1,000     1,959,000           1,960,000
Issuance of Common Stock and Warrants, net of issuance costs ( in shares)     918,600                  
Preferred Stock conversion to Common       $ 2,005,000 $ 728,000         $ 2,005,000 $ 728,000  
Preferred Stock conversion to Common (in shares) 72,132 26,230                    
Conversion of Pre-Funded Warrants to Common (in shares)     509,987                  
Foreign currency exchange gain (loss)               (1,210,000)       (1,210,000)
Net loss             (25,653,000)         (25,653,000)
Balance at Dec. 31, 2024     $ 3,000     355,501,000 (334,971,000) (1,178,000) (288,000)     19,067,000
Balance (in shares) at Dec. 31, 2024     2,811,259                  
Stock-based compensation           654,000           654,000
Stock issued under "at-the-market" offering     $ 18,000     6,815,000           6,833,000
Stock issued under "at-the-market" offering (in shares)     17,998,117                  
Issuance of Common Stock and Warrants, net of issuance costs     $ 2,000     6,688,000           6,690,000
Issuance of Common Stock and Warrants, net of issuance costs ( in shares)     1,990,900                  
Warrant Inducement, net of issuance costs     $ 8,000     3,933,000           3,941,000
Warrant Inducement, net of issuance costs (in shares)     8,092,280                  
Conversion of Pre-Funded Warrants to Common     $ 3,000     1,000           4,000
Conversion of Pre-Funded Warrants to Common (in shares)     4,824,603                  
Foreign currency exchange gain (loss)               1,933,000       1,933,000
Net loss             (23,739,000)         (23,739,000)
Balance at Dec. 31, 2025     $ 34,000     $ 373,592,000 $ (358,710,000) $ 755,000 $ (288,000)     $ 15,383,000
Balance (in shares) at Dec. 31, 2025     35,717,159